FDA Investigator Dianna D Wardlow Dotter

Dianna D Wardlow Dotter has inspections in 1 countries as of 08 Nov 2023. Dianna D Wardlow Dotter has collaborated with a combinined 2100 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
82
Last Inspection Date:
08 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100008509
Country:
United States of America
Co-Investigator(s):
Alan P Kurtzberg, Alanna Lmussawwir Bias, Alejandro Rodriguez, Alexander M Kay, Alicia A Borg Borm, Andrea J Schmidt, Andrew M Kolenc, Ava M Bowman, Avery J Dennis, Barbara J White, Barbara T Carmichael, Betty K Baxter, Brenda L Reihing, Brent W Higgs, Brentley S Collins, Brittany R Laymon, Bryan Baker, Carla R Hinz, Ce'nedra M Martin, Christopher S Genther, Cynthia L Gorveatt, Dan G Eisenbrey, Daniel J Lahar, Daniel Pst Laurent, Dawn E Barkans, Deborah S Hammond, Debra L Curtis, Dennis G Kawabata, Dennis R Hudson, Dolores E Price, Donald W Jehn, Edith M Gonzalez, Edward D Harris, Elaine G Stewart, Elmina E Akwo, Emily B Camire, Eric S Myskowski, Eric T Huebler, Felicia M Orlando, Francisco J Mendoza, Frank L Cordova, Garrad R Poole, Gloria A Milster, Gloria J Baca, MS, Hanna L Potter, Heika R Tait, Holly L Miller, Ismael Olvera, IV, James D Romero, Jennifer A Baker, Jennifer R Mathern, Jessica B Clark, Jessica L Walters Moell, John A Iwen, Jonathan R Campos, Julian C Hanson, Kaarin M Slotte, Karen G Hirshfield, Kathleen S Tormey, Kathryn A Krentz, Kathryn M Mogen, Kelly D Moore, Kristen E Szenderski, Larisa E Pavlick, Larry Gehring, Lauren E Swantko, Lesley A Swanson, Linda M Cheny, Lori J Silverstein, Marc A Jackson, Jr, Marie Bbuen Bigornia, Mark W Babbitt, Marsha L Mccauley, Martina E Lagrange, Mary F Bodick, Matthew A Kozler, Matthew J Hansen, Matthew R Dionne, Michael J Kuchta, Michael L Zimmerman, Michael R Goga, Mihaly S Ligmond, Nancy G Schmidt, Nathan M Jornod, Ngoc Lant Nguyen, Olious D Evans, Oluwaseyi Ojinni, Ounchith J Phabmixay, Patricia A Brown, Patricia A Maestas, Paul J Teitell, Paul M Chefor, Peter Kessler, PhD, Prabhu P Raju, Rebecca T Davis, Richard G Runyon, Richard Heath Coats, Richard J Bashay, Robert D Tollefsen, Rocco C Black, Sarah J Cullen, Sheila Alaghemand, Shererk, State Agency, Stephen R Souza, Steve P Yost, Sunitha K Rajaram, PhD, Teena H Aiken, Theressa B Smith, Traci B Bickell, Travis S Bradley, Trevor R Beach, Trinidad D Barreras, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, William H Sherer, Zachary L Miller, Zachary P Wachlarowicz

Dianna D Wardlow Dotter's Documents

Publish Date Document Type Title
June, 2012 FDA 483 International Cellular Medicine Society IRB - Form 483, 2012-06-19
February, 2013 FDA 483 Bloodworks - Form 483, 2013-02-15
February, 2013 FDA 483 Response Bloodworks - Form 483R, 2013-03-05

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more